Biological correlates of treatment resistant depression: a review of peripheral biomarkers

被引:0
|
作者
Mancuso, Emiliana [1 ]
Sampogna, Gaia [1 ]
Boiano, Alessia [1 ]
Della Rocca, Bianca [1 ]
Di Vincenzo, Matteo [1 ]
Lapadula, Maria Vita [1 ]
Martinelli, Flavia [1 ]
Lucci, Federico [1 ]
Luciano, Mario [1 ]
机构
[1] Univ Campania L Vanvitelli, Dept Psychiat, Caserta, Italy
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
major depression; treatment resistant depression; TRD; biomarker; cytokines; inflammation; MAJOR DEPRESSION; MENTAL-DISORDERS; ELECTROCONVULSIVE-THERAPY; ANTIDEPRESSANT TREATMENT; INFLAMMATORY CYTOKINES; HIERARCHICAL TAXONOMY; RISK; PSYCHOPATHOLOGY; PSYCHOTHERAPIES; DIAGNOSIS;
D O I
10.3389/fpsyt.2023.1291176
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IntroductionMany patients fail to respond to multiple antidepressant interventions, being defined as "treatment-resistant depression" (TRD) patients. TRD is usually associated with increased severity and chronicity of symptoms, increased risk of comorbidity, and higher suicide rates, which make the clinical management challenging. Efforts to distinguish between TRD patients and those who will respond to treatment have been unfruitful so far. Several studies have tried to identify the biological, psychopathological, and psychosocial correlates of depression, with particular attention to the inflammatory system. In this paper we aim to review available studies assessing the full range of biomarkers in TRD patients in order to reshape TRD definition and improve its diagnosis, treatment, and prognosis.MethodsWe searched the most relevant medical databases and included studies reporting original data on possible biomarkers of TRD. The keywords "treatment resistant depression" or "TRD" matched with "biomarker," "inflammation," "hormone," "cytokine" or "biological marker" were entered in PubMed, ISI Web of Knowledge and SCOPUS databases. Articles were included if they included a comparison with healthy controls (HC).ResultsOf the 1878 papers identified, 35 were included in the present study. Higher plasma levels of IL-6 and TNF-alpha were detected in TRD patients compared to HC. While only a few studies on cortisol have been found, four papers showed elevated levels of C-reactive protein among these patients and four articles focused on immunological cells. Altered kynurenine metabolism in TRD patients was reported in two studies, while contrasting results were found with regard to BDNF.ConclusionOnly a few biological alterations correlate with TRD. TNF-alpha seems to be the most relevant biomarker to discriminate TRD patients from both HC and treatment-responsive MDD patients. Moreover, several discrepancies among studies have been found, due to methodological differences and the lack of a standardized diagnostic definition of TRD.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] CLINICAL AND BIOLOGICAL CORRELATES OF TREATMENT-RESISTANT DEPRESSION - AN OVERVIEW
    HORNIGROHAN, M
    AMSTERDAM, JD
    [J]. PSYCHIATRIC ANNALS, 1994, 24 (05) : 220 - 227
  • [2] Lactate and lactate-to-pyruvate ratio as a peripheral biomarkers of treatment-resistant depression
    Scaini, Giselli
    Wartchow, Krista M.
    Cordeiro, Rafaela C.
    Asir, Bashar
    Zunta-Soares, Giovana
    Fenoy, Albert J.
    Soares, Jair C.
    de Quevedo, Joao Luciano
    [J]. BIPOLAR DISORDERS, 2023, 25 : 100 - 100
  • [3] Lactate and Lactate-To-Pyruvate Ratio as a Peripheral Biomarkers of Treatment-Resistant Depression
    Cordeiro, Rafaela Carneiro
    Wartchow, Krista M.
    Li, Tina
    Asi, Bashar
    Zunta-Soares, Giovana
    Fenoy, Albert J.
    Soares, Jair C.
    Quevedo, Joao
    Scaini, Giselli
    [J]. BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S318 - S319
  • [5] Neurobiological Correlates of Anhedonia in Treatment Resistant Depression
    Rizvi, Sakina J.
    Strafella, Antonio
    Rusjan, Pablo
    Sproule, Beth
    Kennedy, Sidney
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 192S - 193S
  • [6] MicroRNAs as biomarkers for treatment-resistant depression
    Gururajan, A.
    Naughton, M. E.
    Scott, K. A.
    Moloney, G.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    McLoughlin, D. M.
    Dinan, T. G.
    Cryan, J. F.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 118 - 118
  • [7] Epigenetic Modifications of Stress-Relevant Genes as Peripheral Biomarkers of Treatment-Resistant Depression
    Pfeiffer, John
    Bustamante, Angela
    Price, Joshua
    Tye, Susannah
    Uddin, Monica
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S203 - S204
  • [8] A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
    Lopresti, Adrian L.
    Maker, Garth L.
    Hood, Sean D.
    Drummond, Peter D.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 48 : 102 - 111
  • [9] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
  • [10] Peripheral thyroid hormone levels in treatment resistant depression
    Joffe, RT
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 1053 - 1055